UBS Group
PFE icon

UBS Group’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$577M Sell
23,817,659
-1,232
-0% -$29.9K 0.1% 163
2025
Q1
$604M Sell
23,818,891
-3,220,014
-12% -$81.6M 0.11% 152
2024
Q4
$717M Buy
27,038,905
+3,795,376
+16% +$101M 0.13% 120
2024
Q3
$673M Buy
23,243,529
+3,292,353
+17% +$95.3M 0.15% 103
2024
Q2
$558M Buy
19,951,176
+3,334,517
+20% +$93.3M 0.14% 113
2024
Q1
$461M Buy
16,616,659
+1,560,892
+10% +$43.3M 0.11% 133
2023
Q4
$433M Buy
15,055,767
+338,325
+2% +$9.74M 0.13% 126
2023
Q3
$488M Sell
14,717,442
-1,749,197
-11% -$58M 0.17% 98
2023
Q2
$604M Sell
16,466,639
-2,153,286
-12% -$79M 0.2% 85
2023
Q1
$760M Buy
18,619,925
+726,356
+4% +$29.6M 0.28% 60
2022
Q4
$917M Buy
17,893,569
+2,991,764
+20% +$153M 0.34% 47
2022
Q3
$652M Sell
14,901,805
-2,177,923
-13% -$95.3M 0.29% 59
2022
Q2
$895M Buy
17,079,728
+294,801
+2% +$15.5M 0.37% 41
2022
Q1
$869M Sell
16,784,927
-708,211
-4% -$36.7M 0.29% 59
2021
Q4
$1.03B Buy
17,493,138
+200,653
+1% +$11.8M 0.3% 46
2021
Q3
$744M Buy
17,292,485
+251,439
+1% +$10.8M 0.23% 75
2021
Q2
$667M Sell
17,041,046
-1,742,222
-9% -$68.2M 0.22% 84
2021
Q1
$681M Sell
18,783,268
-1,965,358
-9% -$71.2M 0.23% 78
2020
Q4
$764M Buy
20,748,626
+2,806,697
+16% +$103M 0.26% 60
2020
Q3
$658M Buy
17,941,929
+1,646,423
+10% +$60.4M 0.25% 75
2020
Q2
$533M Sell
16,295,506
-845,241
-5% -$27.6M 0.23% 86
2020
Q1
$559M Sell
17,140,747
-3,841,309
-18% -$125M 0.26% 67
2019
Q4
$822M Sell
20,982,056
-1,931,768
-8% -$75.7M 0.29% 56
2019
Q3
$823M Sell
22,913,824
-140,574
-0.6% -$5.05M 0.32% 53
2019
Q2
$999M Buy
23,054,398
+3,891,947
+20% +$169M 0.38% 46
2019
Q1
$814M Sell
19,162,451
-1,730,732
-8% -$73.5M 0.34% 53
2018
Q4
$912M Sell
20,893,183
-113,039
-0.5% -$4.93M 0.41% 36
2018
Q3
$926M Sell
21,006,222
-927,532
-4% -$40.9M 0.37% 46
2018
Q2
$796M Buy
21,933,754
+1,016,973
+5% +$36.9M 0.34% 48
2018
Q1
$742M Sell
20,916,781
-993,328
-5% -$35.3M 0.32% 54
2017
Q4
$794M Buy
21,910,109
+1,325,439
+6% +$48M 0.33% 49
2017
Q3
$735M Buy
20,584,670
+255,924
+1% +$9.14M 0.34% 46
2017
Q2
$683M Buy
20,328,746
+511,692
+3% +$17.2M 0.35% 50
2017
Q1
$678M Buy
19,817,054
+2,515,107
+15% +$86M 0.37% 42
2016
Q4
$562M Buy
17,301,947
+685,908
+4% +$22.3M 0.31% 49
2016
Q3
$563M Buy
16,616,039
+1,527,440
+10% +$51.7M 0.34% 46
2016
Q2
$531M Sell
15,088,599
-348,495
-2% -$12.3M 0.33% 43
2016
Q1
$458M Sell
15,437,094
-2,504,405
-14% -$74.2M 0.31% 52
2015
Q4
$579M Buy
17,941,499
+2,081,694
+13% +$67.2M 0.38% 35
2015
Q3
$498M Sell
15,859,805
-1,072,491
-6% -$33.7M 0.35% 38
2015
Q2
$568M Buy
16,932,296
+1,276,931
+8% +$42.8M 0.38% 33
2015
Q1
$545M Sell
15,655,365
-5,961,047
-28% -$207M 0.38% 33
2014
Q4
$673M Buy
+21,616,412
New +$673M 0.47% 20